Explore
Validate
Learn
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14-9960-82 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- HAI-1 Monoclonal Antibody (9B10), eBioscience™
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Description: The monoclonal antibody 9B10 recognizes HAI-1 also known as hepatocyte growth factor activation inhibitor. HAI-1 is a single transmembrane protein of approximately 53 kDa with an extracellular Kunitz-type serine protease inhibitor domain. HAI-1 and HAI-2 are produced in membrane-associated forms, which are secreted as active, proteolytically truncated proteins. HAI can bind to and inhibit HGFA and matripase, which are responsible for converting HGF to an active form. Human HAI-1 transcript is expressed in various human tissues, such as adult placenta, kidney, pancreas, prostate, small intestine, fetal kidney and fetal lung. HAI-1 is a marker for prostate and breast cancers.
- Antibody clone number
- 9B10
- Concentration
- 0.5 mg/mL
Submitted references Cytotrophoblast, Not Syncytiotrophoblast, Dominates Glycolysis and Oxidative Phosphorylation in Human Term Placenta.
Real-Time Tracking of BODIPY-C12 Long-Chain Fatty Acid in Human Term Placenta Reveals Unique Lipid Dynamics in Cytotrophoblast Cells.
The hepatocyte growth factor regulatory factors in human breast cancer.
Kolahi KS, Valent AM, Thornburg KL
Scientific reports 2017 Feb 23;7:42941
Scientific reports 2017 Feb 23;7:42941
Real-Time Tracking of BODIPY-C12 Long-Chain Fatty Acid in Human Term Placenta Reveals Unique Lipid Dynamics in Cytotrophoblast Cells.
Kolahi K, Louey S, Varlamov O, Thornburg K
PloS one 2016;11(4):e0153522
PloS one 2016;11(4):e0153522
The hepatocyte growth factor regulatory factors in human breast cancer.
Parr C, Watkins G, Mansel RE, Jiang WG
Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Jan 1;10(1 Pt 1):202-11
Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Jan 1;10(1 Pt 1):202-11
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Staining of MCF7 cell line with 0.25 µg of Mouse IgG2a K Isotype Control Purified (Product # 14-4724-82) (open histogram) or 0.25 µg of Anti-Human HAI-1 Purified (filled histogram) followed by F (ab')2 Anti-Mouse IgG PE (Product # 12-4012). Total viable cells were used for analysis.
